Correlation Between Black Diamond and Bluebird Bio

Can any of the company-specific risk be diversified away by investing in both Black Diamond and Bluebird Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Black Diamond and Bluebird Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Black Diamond Therapeutics and Bluebird bio, you can compare the effects of market volatilities on Black Diamond and Bluebird Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Black Diamond with a short position of Bluebird Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Black Diamond and Bluebird Bio.

Diversification Opportunities for Black Diamond and Bluebird Bio

0.59

Correlation Coefficient

Black Diamond  Bluebird Bio

Very weak diversification

The 3 months correlation between Black and Bluebird is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Black Diamond Therapeutics and Bluebird bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bluebird bio and Black Diamond is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Black Diamond Therapeutics are associated (or correlated) with Bluebird Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bluebird bio has no effect on the direction of Black Diamond i.e., Black Diamond and Bluebird Bio go up and down completely randomly.

Pair Corralation between Black Diamond and Bluebird Bio

Given the investment horizon of 90 days Black Diamond is expected to generate 18.36 times less return on investment than Bluebird Bio. But when comparing it to its historical volatility, Black Diamond Therapeutics is 11.28 times less risky than Bluebird Bio. It trades about 0.03 of its potential returns per unit of risk. Bluebird bio is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  383.00  in Bluebird bio on September 14, 2024 and sell it today you would earn a total of  258.50  from holding Bluebird bio or generate 67.49% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Black Diamond Therapeutics  vs.  Bluebird bio

Black Diamond Therap

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Black Diamond Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Bluebird bio

Risk-Adjusted Performance

9 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Bluebird bio are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Bluebird Bio exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Black Diamond and Bluebird Bio

The main advantage of trading using opposite Black Diamond and Bluebird Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Black Diamond position performs unexpectedly, Bluebird Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bluebird Bio will offset losses from the drop in Bluebird Bio's long position.

The idea behind Black Diamond Therapeutics and Bluebird bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.